v3.26.1
Balance Sheet Components
6 Months Ended
Jun. 30, 2026
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Components

5. Balance Sheet Components

Accrued Liabilities

Accrued liabilities consisted of the following:

 

 

 

June 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

 

 

(in thousands)

 

Accrued clinical trial and preclinical costs

 

 

11,873

 

 

 

13,577

 

Compensation and benefits

 

 

6,972

 

 

 

11,494

 

Research grant funding

 

 

3,068

 

 

 

2,379

 

Professional services

 

 

847

 

 

 

614

 

Other

 

 

571

 

 

 

724

 

Total accrued liabilities

 

$

23,331

 

 

$

28,788